Silexion Therapeutics Ltd. (SLXN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Silexion Therapeutics Ltd...

    NASDAQ: SLXN · Real-Time Price · USD
    7.07
    -0.07 (-1.03%)
    At close: Sep 04, 2025, 3:46 PM
    7.26
    2.75%
    After-hours: Sep 04, 2025, 06:39 PM EDT

    Silexion Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 25K n/a n/a n/a
    Gross Profit
    		 -25K n/a n/a n/a
    Operating Income
    		 -12.57M -4.68M -3.86M -943.93K
    Interest Income
    		 1K 153K 114K 6.37K
    Pretax Income
    		 -16.51M -5.08M -3.46M -755.22K
    Net Income
    		 16.51M -4.94M -3.21M -755K
    Selling & General & Admin
    		 6.76M 928K 577K 943.93K
    Research & Development
    		 5.82M 3.71M 3.23M n/a
    Other Expenses
    		 n/a 45K 57K n/a
    Operating Expenses
    		 12.57M 4.68M 3.86M 943.93K
    Interest Expense
    		 52K 9K 85K n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 12.57M 4.68M 3.86M 943.93K
    Income Tax Expense
    		 10K 32K 24K n/a
    Shares Outstanding (Basic)
    		 6.24M 1.12M 16.73M 16.51M
    Shares Outstanding (Diluted)
    		 6.24M 1.12M 16.73M 16.51M
    EPS (Basic)
    		 -2.64 -4.42 0.03 -0.05
    EPS (Diluted)
    		 -2.64 -4.42 0.03 -0.05
    EBITDA
    		 -16.43M -4.64M -3.8M -755K
    EBIT
    		 -16.46M -4.68M -3.86M -755K
    Depreciation & Amortization
    		 25K 45K 57K n/a

    Add to Watchlist